RESTATEMENT OF PRIOR PERIOD AMOUNTS (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
Additional paid in capital | $ 118,859,772 | $ 118,859,772 | $ 118,681,086 | ||
Accumulated Deficit | (106,721,452) | (106,721,452) | $ (105,801,600) | ||
Net loss | (771,906) | $ (201,977) | (919,852) | $ (323,555) | |
Loss from sale of investment | 647,462 | 112,187 | |||
Gain/(Loss) from sale of investment | (647,462) | (112,187) | |||
As previously reported [Member] | |||||
Gain/(Loss) on investment | 87,403 | 148,972 | |||
Other income/(expense), net | 87,614 | 148,781 | |||
Additional paid in capital | 103,714,814 | 103,714,814 | |||
Accumulated Deficit | 104,782,949 | 104,782,949 | |||
Net loss | 53,740 | 62,396 | |||
Loss from sale of investment | (62,396) | ||||
Gain/(Loss) from sale of investment | 62,396 | ||||
Adjustment [Member] | |||||
Gain/(Loss) on investment | (148,236) | (261,159) | |||
Other income/(expense), net | (148,236) | (261,159) | |||
Additional paid in capital | 14,990,000 | 14,990,000 | |||
Accumulated Deficit | 261,159 | 261,159 | |||
Net loss | 148,236 | 261,159 | |||
Loss from sale of investment | (261,159) | ||||
Gain/(Loss) from sale of investment | 261,159 | ||||
As restated [Member] | |||||
Gain/(Loss) on investment | (60,833) | (112,187) | |||
Other income/(expense), net | (60,622) | (112,378) | |||
Additional paid in capital | 118,704,814 | 118,704,814 | |||
Accumulated Deficit | $ 105,044,108 | $ 105,044,108 | |||
Net loss | $ 201,976 | 323,555 | |||
Loss from sale of investment | (112,187) | ||||
Gain/(Loss) from sale of investment | $ 112,187 |
X | ||||||||||
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of an equity method investment. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|